why choose us

First received: February 01, 2024

Clinical Trial: Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Respiratory Syncytial Virus Infection

Study Type: INTERVENTIONAL


Official Title: A Phase IIb, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of an RSV Vaccine Candidate in Adult Participants 60 Years and Older

Brief Summary: The purpose of this Phase IIb study is to evaluate the efficacy of the RSV vaccine candidate for the prevention of lower respiratory tract disease (LRTD) due to RSV.The study will enroll approximately 4500 adults aged 60 years and older in a 1:1 ratio to receive a single intra-muscular (IM) administration of either a pre-determined dose of the RSV vaccine candidate or placebo.

Read more